Navigation Links
Alma Lasers Announces FDA Clearance of the Harmony(XL) Multi-Application System at THE Aesthetic Show 2008
Date:5/29/2008

Innovative Technology Offers Patients 60 Different Medical and Aesthetic

Treatments

LAS VEGAS, May 29 /PRNewswire/ -- Alma Lasers Ltd. ("Alma Lasers"), a global developer and marketer of laser, light, and radiofrequency based aesthetic devices, announced today at THE Aesthetic Show 2008 FDA clearance for its Harmony(XL), the newest platform for multiple aesthetic laser and light treatments. The Harmony(XL) can be used to treat more than 60 popular aesthetic indications and applications, including acne, skin rejuvenation, hair removal, varicose veins, stretch marks, tattoo removal, wrinkles and skin tightening.

The Harmony(XL) device is the most comprehensive and versatile platform to enter the medical and aesthetic industry, as it is the first to combine lasers, pulsed light, near-infrared, LED and UVB technologies with multiple exchangeable handpieces to ensure easy and effective singular and combined therapeutic treatment. The Harmony(XL) also accommodates new versions of Alma's unique Advanced Fluorescence Technology (AFT) and several different laser technologies. Compared to its successful predecessor, Harmony(XL) delivers higher energy and is the first Harmony model to incorporate Alma's proprietary IN-Motion(TM) technology, which delivers effective energy with virtually no discomfort over a range of applications. Additionally, the Harmony(XL) exclusively offers high-power Pixel(R) 2940 technology -- a breakthrough for fractionated skin resurfacing treatments.

"The FDA clearance of the Harmony(XL) reinforces Alma Lasers' commitment to developing and marketing innovative treatments for patients with every skin type and skin concern," said Howard Kelly, CEO of Alma Lasers. "While other systems in the market claim versatility by merging technologies or providing multiple handpieces, no other aesthetic system offers as many combined treatment possibilities and performance as the Harmony(XL)."

Every Harmony(XL) handpiece is designed for maximum effectiveness with minimal patient discomfort. One of the most popular options is the Laser360(TM) skin rejuvenation treatment. The new procedure uses three handpieces from the Harmony(XL) system to treat a wide range of age and photo-damage symptoms. Patients can achieve outstanding results in just 60 days, with minimal or no downtime.

"To give patients a complete treatment, oftentimes physicians need two, three or four different lasers, but with the Harmony(XL) you have one platform with different handpieces, taking the place of larger devices. You can start with one handpiece, treat, and then quickly and easily switch to a different one," said Dr. Stuart Melnick, Medical Director, Laser and Cosmetic Center in Los Gatos, CA.

About Alma Lasers

Alma Lasers is a global medical technology company that designs, develops, manufactures and markets laser, intense pulsed light and radiofrequency based aesthetic treatment devices that can be used to treat a broad range of skin types and indications. Alma Lasers believes that its products have typically been at the forefront of technological development in the energy-based aesthetic treatment system market. Since commercializing its first aesthetic treatment system in 2002, Alma Lasers has introduced multiple systems that work in combination with more than 25 handpieces. Alma Lasers' mission is to leverage its technical expertise and in-depth understanding of practitioners' needs in order to provide modular, cost-effective and high performance designs that enable medical practitioners to confidently offer safe, effective and profitable aesthetic treatments to their patients.

Alma Lasers. Wellbeing Through Technology.


'/>"/>
SOURCE Alma Lasers
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Lumenis Sues Alma Lasers and its 4 founders for 200 Million Shekels
2. Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology
3. Alma Lasers Announces Proposed Initial Public Offering
4. Alma Lasers Answers Lumenis Complaint
5. Darwin Announces Creation of New Health Care and Errors and Omissions Divisions
6. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
7. Ekahau Announces Compatibility With 802.11n
8. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
9. DRAXIS Announces Completion of Sale to Jubilant
10. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
11. Hill-Rom Announces Third Quarter 2008 Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: